In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 22 | Yes |
Popular Name: N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride N-(3-Chlorophenyl)-6,7-dimethoxy…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 153436-53-4 , 153436-53-4; 170449-18-0 , 170449-18-0 , 175178-82-2 , [170449-18-0]
4-(3-Chloroanilino)-6,7-dimethoxyquinazoline
4-(3-Chloroanilino)-6,7-dimethoxyquinazoline hydrochloride
4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-, hydrochloride (1:1)
4-Quinazolinamine,N-(3-chlorophenyl)-6,7-dimethoxy-
AG1478; CPD000466282; SAM001247079
N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine
N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-aminehydrochloride
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.93 | 8.47 | -10.66 | 1 | 5 | 0 | 56 | 315.76 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 95% | Fluorochem |
Purity | >98% | Fluorochem |
Target | EGFR | Selleck Chemicals |
Indications | EGFR inhibitor | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 1276; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 1276; SALT: 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 125 | 0.44 | Binding ≤ 10μM |
ABL2-1-E | Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 125 | 0.44 | Binding ≤ 10μM |
EGFR-3-E | Epidermal Growth Factor Receptor ErbB1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 6 | 0.52 | Binding ≤ 10μM |
F16P1-2-E | Fructose-1,6-bisphosphatase 1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1300 | 0.37 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 5000 | 0.34 | Binding ≤ 10μM |
MK14-3-E | MAP Kinase P38 Alpha (cluster #3 Of 3), Eukaryotic | Eukaryotes | 560 | 0.40 | Binding ≤ 10μM |
MKNK1-1-E | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 530 | 0.40 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2700 | 0.35 | Binding ≤ 10μM |
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 100 | 0.45 | Functional ≤ 10μM |
Z100492-1-O | MCF10 (Normal Breast Epithelial Cells) (cluster #1 Of 1), Other | Other | 173 | 0.43 | Functional ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 7943 | 0.32 | Functional ≤ 10μM |
Z80037-1-O | Balb/MK (cluster #1 Of 1), Other | Other | 100 | 0.45 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 1982 | 0.36 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1.26 | 0.57 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 560 | 0.40 | Binding ≤ 1μM |
MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 530 | 0.40 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 125 | 0.44 | Binding ≤ 1μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 125 | 0.44 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1.26 | 0.57 | Binding ≤ 10μM |
F16P1_HUMAN | P09467 | Fructose-1,6-bisphosphatase, Human | 1300 | 0.37 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 560 | 0.40 | Binding ≤ 10μM |
MKNK1_HUMAN | Q9BUB5 | MAP Kinase-interacting Serine/threonine-protein Kinase MNK1, Human | 530 | 0.40 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 125 | 0.44 | Binding ≤ 10μM |
ABL2_HUMAN | P42684 | Tyrosine-protein Kinase ABL2, Human | 125 | 0.44 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 5000 | 0.34 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 2700 | 0.35 | Binding ≤ 10μM |
Z80037 | Z80037 | Balb/MK | 100 | 0.45 | Functional ≤ 10μM |
EGFR_MOUSE | Q01279 | Epidermal Growth Factor Receptor ErbB1, Mouse | 100 | 0.45 | Functional ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 0.8 | 0.58 | Functional ≤ 10μM |
Z100492 | Z100492 | MCF10 (Normal Breast Epithelial Cells) | 173 | 0.43 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 1982 | 0.36 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 7943.28235 | 0.32 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downstream TCR signaling | |
DSCAM interactions | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
ERK/MAPK targets | |
Factors involved in megakaryocyte development and platelet production | |
GAB1 signalosome | |
Generation of second messenger molecules | |
Gluconeogenesis | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
Interleukin-2 signaling | |
KSRP destabilizes mRNA | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
Platelet sensitization by LDL | |
PLCG1 events in ERBB2 signaling | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of KIT signaling | |
Role of Abl in Robo-Slit signaling | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by SCF-KIT | |
Spry regulation of FGF signaling | |
Translocation of ZAP-70 to Immunological synapse | |
VEGFA-VEGFR2 Pathway |